Law firm Mills & Reeve has appointed Dan Braithwaite as a principal associate in its health and social care mergers and acquisitions practice.
Phlo Technologies: Alistair Murray
Glasgow-based digital pharmacy company Phlo Technologies has appointed Alistair Murray as chief pharmacist.
An experienced prescribing pharmacist and a digital pharmacy compliance expert, Murray will provide strategic leadership and help steer Phlo’s growth. He brings to the team experience in scaling digital pharmacy products, and in delivering patient access programmes in partnership with local and national commissioners.
Murray was the founding clinician at online pharmacy Echo, where he was involved in the conception and launch of the company and later oversaw patient safety, operations and regulatory compliance as part of the senior leadership team. In 2019, following years of scaling, Echo was acquired by LloydsPharmacy.
Murray is a fellow of the UK Faculty of Clinical Informatics, and previously held honorary teaching roles at University College London and the University of Nottingham.
Adam Hunter, chief commercial officer at Phlo Technologies, said: “Alistair brings the perfect mix of perspective and insight to Phlo’s senior leadership team. His unique combination of clinical and regulatory experience, and his track record in digital pharmacy, make him the ideal person to take on the role of chief pharmacist.
“As a company, we are in the midst of an ambitious and successful expansion phase. We’re also working continuously to improve the services and technologies that we offer to our healthtech partners. Alistair’s appointment will strengthen our work to elevate the UK digital pharmacy sector with best-in-class technologies and solutions.”
Murray commented: “It is an incredibly exciting time to be joining the senior leadership team at Phlo. In the wake of an impressive raise and a sector-first acquisition earlier in 2023, their work to transform the UK’s digital pharmacy landscape continues to display impressive momentum. As the Phlo chief pharmacist, I will be working closely with the team and our partner organisations to ensure the continued success of our regional expansion and new product development.
“Phlo is in a unique position with its API-enabled connectivity with B2B partners to provide a secure, timely, safe and accurate service. I’m already hard at work getting us ready for our next phase of scaling, and patient safety, clinical excellence, and operational efficiency are at the heart of this. There is an excellent in-house team to enable us to achieve our goals and beyond.
Latest Executive Moves
Cancer Research Horizons has appointed Jonathan Tobin and Genghis Lloyd-Harris as advisory investors-in-residence in its ventures team.Pharma